These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32157797)

  • 1. Umbilical vein injection of 400 versus 800 μg misoprostol for the treatment of retained placenta: A multicenter, randomized double-blind controlled trial.
    Alalaf SK; Al Tawil NG; Jawad AK; Mahmoud MB; Muhamad BQ; Abdul Rahman KH; Sileem SA; Hassan JN; Ameen KM; Mustafa SA; Bawadikji AA
    J Obstet Gynaecol Res; 2020 May; 46(5):727-735. PubMed ID: 32157797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical vein injection of misoprostol versus normal saline for the treatment of retained placenta: intrapartum placebo-controlled trial.
    Rajab SS; Alalaf SK
    BMC Pregnancy Childbirth; 2014 Jan; 14():37. PubMed ID: 24444360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consecutive intra-umbilical vein injection of misoprostol and intravenous sulprostone in the management of retained placenta.
    Notten F; Meertens L; Wissink B; Scheepers HC
    Arch Gynecol Obstet; 2014 Jan; 289(1):35-40. PubMed ID: 23771186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No reduction of manual removal after misoprostol for retained placenta: a double-blind, randomized trial.
    van Stralen G; Veenhof M; Holleboom C; van Roosmalen J
    Acta Obstet Gynecol Scand; 2013 Apr; 92(4):398-403. PubMed ID: 23231499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraumbilical injection of three different uterotonics in the management of retained placenta.
    Harara R; Hanafy S; Zidan MS; Alberry M
    J Obstet Gynaecol Res; 2011 Sep; 37(9):1203-7. PubMed ID: 21518127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different routes and forms of uterotonics for treatment of retained placenta: a randomized clinical trial.
    Maher MA; Sayyed TM; Elkhouly NI
    J Matern Fetal Neonatal Med; 2017 Sep; 30(18):2179-2184. PubMed ID: 27677547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial on the value of misoprostol for the treatment of retained placenta in a low-resource setting.
    van Beekhuizen HJ; Tarimo V; Pembe AB; Fauteck H; Lotgering FK
    Int J Gynaecol Obstet; 2013 Sep; 122(3):234-7. PubMed ID: 23791153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-umbilical vein injection of carbetocin versus oxytocin in the management of retained placenta.
    Salem MAA; Saraya YS; Badr MS; Soliman AM
    Sex Reprod Healthc; 2019 Oct; 21():21-25. PubMed ID: 31395229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta.
    Rogers MS; Yuen PM; Wong S
    Acta Obstet Gynecol Scand; 2007; 86(1):48-54. PubMed ID: 17230289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of retained placenta with misoprostol: a randomised controlled trial in a low-resource setting (Tanzania).
    van Beekhuizen HJ; Pembe AB; Fauteck H; Lotgering FK
    BMC Pregnancy Childbirth; 2009 Oct; 9():48. PubMed ID: 19852814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraumbilical vein injection of prostaglandin F2 alpha in retained placenta.
    Bider D; Dulitzky M; Goldenberg M; Lipitz S; Mashiach S
    Eur J Obstet Gynecol Reprod Biol; 1996 Jan; 64(1):59-61. PubMed ID: 8801151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trial protocol.
    Gattás DSMB; da Silva Junior JR; Souza ASR; Feitosa FE; de Amorim MMR
    Reprod Health; 2018 Apr; 15(1):65. PubMed ID: 29669596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical vein oxytocin in the management of retained placenta: an alternative to manual removal of placenta?
    Lim PS; Singh S; Lee A; Muhammad Yassin MA
    Arch Gynecol Obstet; 2011 Nov; 284(5):1073-9. PubMed ID: 21136267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of a retained placenta with intraumbilical oxytocin injection.
    Habek D; Hrgović Z; Ivanisević M; Delmis J
    Zentralbl Gynakol; 2001 Jul; 123(7):415-7. PubMed ID: 11534303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial.
    Weeks AD; Alia G; Vernon G; Namayanja A; Gosakan R; Majeed T; Hart A; Jafri H; Nardin J; Carroli G; Fairlie F; Raashid Y; Mirembe F; Alfirevic Z
    Lancet; 2010 Jan; 375(9709):141-7. PubMed ID: 20004013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral misoprostol after second-trimester delivery: a randomized, blinded study.
    Leader J; Bujnovsky M; Carlan SJ; Triana T; Richichi K
    Obstet Gynecol; 2002 Oct; 100(4):689-94. PubMed ID: 12383535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intra-umbilical oxytocin in the management of retained placenta: a randomized controlled trial.
    Samanta A; Roy SG; Mistri PK; Mitra A; Pal R; Naskar A; Bhattacharya SK; Pal PP; Pande A
    J Obstet Gynaecol Res; 2013 Jan; 39(1):75-82. PubMed ID: 22889466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.
    Blum J; Winikoff B; Raghavan S; Dabash R; Ramadan MC; Dilbaz B; Dao B; Durocher J; Yalvac S; Diop A; Dzuba IG; Ngoc NT
    Lancet; 2010 Jan; 375(9710):217-23. PubMed ID: 20060162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Release Trial: a randomised controlled trial of umbilical vein oxytocin versus placebo for the treatment of retained placenta.
    Weeks A; Mirembe F; Alfirevic Z
    BJOG; 2005 Oct; 112(10):1458. PubMed ID: 16167963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of vaginal versus buccal misoprostol for cervical ripening in women for labor induction at term (the IMPROVE trial): a triple-masked randomized controlled trial.
    Haas DM; Daggy J; Flannery KM; Dorr ML; Bonsack C; Bhamidipalli SS; Pierson RC; Lathrop A; Towns R; Ngo N; Head A; Morgan S; Quinney SK
    Am J Obstet Gynecol; 2019 Sep; 221(3):259.e1-259.e16. PubMed ID: 31075246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.